The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis

OBJECTIVES: To investigate changes in BMD in RA patients receiving 3-year biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) or conventional synthetic DMARD (csDMARD). METHODS: Patients with RA were recruited from September 2014 until March 2019. Clinical characteristics...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatology (Oxford)
Hlavní autoři: Chen, Jia-Feng, Hsu, Chung-Yuan, Yu, Shan-Fu, Ko, Chi-Hua, Chiu, Wen-Chan, Lai, Han-Ming, Chen, Ying-Chou, Su, Yu-Jih, Cheng, Tien-Tsai
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Clinical Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449814/
https://ncbi.nlm.nih.gov/pubmed/31984422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez655
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky